SunLink Health Net Worth

SunLink Health Net Worth Breakdown

  SSY
The net worth of SunLink Health Systems is the difference between its total assets and liabilities. SunLink Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of SunLink Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. SunLink Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if SunLink Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in SunLink Health Systems stock.

SunLink Health Net Worth Analysis

SunLink Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including SunLink Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of SunLink Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform SunLink Health's net worth analysis. One common approach is to calculate SunLink Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares SunLink Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing SunLink Health's net worth. This approach calculates the present value of SunLink Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of SunLink Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate SunLink Health's net worth. This involves comparing SunLink Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into SunLink Health's net worth relative to its peers.

Enterprise Value

2.9 Million

To determine if SunLink Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding SunLink Health's net worth research are outlined below:
SunLink Health has some characteristics of a very speculative penny stock
SunLink Health had very high historical volatility over the last 90 days
The company reported the last year's revenue of 32.44 M. Reported Net Loss for the year was (1.53 M) with profit before taxes, overhead, and interest of 4.71 M.
SunLink Health Systems has about 4.49 M in cash with (2.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
SunLink Health has a frail financial position based on the latest SEC disclosures
Roughly 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 28219 shares by Howard Turner of SunLink Health subject to Rule 16b-3
SunLink Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in SunLink Health Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to SunLink Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Follow SunLink Health's market capitalization trends

The company currently falls under 'Nano-Cap' category with a total capitalization of 6.05 M.

Market Cap

7.43 Million

Project SunLink Health's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.08) 0.01 
Return On Capital Employed(0.15)(0.04)
Return On Assets(0.07) 0.01 
Return On Equity(0.10) 0.05 
The company has Net Profit Margin of (0.02) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.15) %, which entails that for every $100 of revenue, it lost $0.15.
When accessing SunLink Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures SunLink Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of SunLink Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in SunLink Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SunLink Health Systems. Check SunLink Health's Beneish M Score to see the likelihood of SunLink Health's management manipulating its earnings.

Evaluate SunLink Health's management efficiency

SunLink Health Systems has Return on Asset of (0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.04). At this time, SunLink Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 24.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 2.27  2.01 
Tangible Book Value Per Share 2.10  1.71 
Enterprise Value Over EBITDA 2.23 (176.45)
Price Book Value Ratio 0.35  0.74 
Enterprise Value Multiple 2.23 (176.45)
Price Fair Value 0.35  0.74 
Enterprise Value3.1 M2.9 M
Leadership at SunLink Health emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue
0.1069
Revenue
31.8 M
Quarterly Revenue Growth
(0.07)
Revenue Per Share
4.518
Return On Equity
(0.15)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SunLink Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on SunLink Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SunLink Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Howard Turner over two weeks ago
Disposition of 28219 shares by Howard Turner of SunLink Health subject to Rule 16b-3
 
Steven Baileys over two weeks ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Howard Turner over two months ago
Acquisition by Howard Turner of 1000 shares of SunLink Health at 0.968 subject to Rule 16b-3
 
Steven Baileys over two months ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Christopher Mills over three months ago
Disposition of 221326 shares by Christopher Mills of SunLink Health at 2.3155 subject to Rule 16b-3
 
Gene Burleson over three months ago
Acquisition by Gene Burleson of 3000 shares of SunLink Health at 0.71 subject to Rule 16b-3
 
Steven Baileys over three months ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Christopher Mills over three months ago
Disposition of 44308 shares by Christopher Mills of SunLink Health at 2.3318 subject to Rule 16b-3
 
Mark Stockslager over three months ago
Acquisition by Mark Stockslager of 30000 shares of SunLink Health at 1.22 subject to Rule 16b-3
 
Gene Burleson over three months ago
Disposition of 3000 shares by Gene Burleson of SunLink Health at 0.71 subject to Rule 16b-3
 
Gene Burleson over six months ago
Acquisition by Gene Burleson of 10000 shares of SunLink Health at 1.38 subject to Rule 16b-3
 
Mark Stockslager over six months ago
Disposition of 30000 shares by Mark Stockslager of SunLink Health subject to Rule 16b-3
SunLink Health time-series forecasting models is one of many SunLink Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SunLink Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

SunLink Health Earnings per Share Projection vs Actual

SunLink Health Corporate Directors

C FordIndependent DirectorProfile
Gene BurlesonIndependent DirectorProfile
Karen BrennerIndependent DirectorProfile
Howard TurnerIndependent DirectorProfile

Additional Tools for SunLink Stock Analysis

When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.